Establish a "Taiwan Rare Disorder Tissue Bank", to Collect and Repost Biological Samples and Disease Information From Patients With Rare Disorders
NCT ID: NCT01384305
Last Updated: 2011-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Verification of the Epidemiology and Mortality of Rare Diseases in Taiwan With Real-world Evidence
NCT05367115
Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center
NCT01311388
The Effects of Allogeneic SLET
NCT04021134
Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
NCT00278044
Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services
NCT00173940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study Period:From 2009 to 2013
2. Study Population:Patients with rare disorders.
3. Planned Number of Subjects: 300\~500 Subjects will be included in CMU.
4. Inclusive Criteria:A patient who is clinically diagnosed as one of rare disorders notified by Department of Health or our organization. Or a patient who is diagnosed as a probable rare disorder case by physicians.
5. Exclusive Criteria:Patients whose physical or mental status is not suitable by the judgment of health professionals. Or a patient who is \<20 years old or interdictory, yet without getting the permission from his/her legal representatives.
6. Study Site: Mainly in OPD that related to rare disorders.
7. Study Materials:Blood (for plasma, DNA and cell line), a questionnaire and a chart review form. Tissue samples are acceptable as well.
8. Application of collected materials:Samples and information will be restored in appropriate manner, and researchers will be encouraged to apply them for biological studies in the field of rare disorders thereafter.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
China Medical University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMR98-IRB-255-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.